Event-Free Survival at 12 Months (EFS12) from Diagnosis Is a Robust Endpoint for Disease-Related Survival in Patients with Follicular Lymphoma in the Immunochemotherapy Era
Year: 2014
Type: article
Study design: Observational Study
Source: Blood
Authors: Matthew J Maurer, Herve Ghesquieres, Stephen M Ansell, Carrie A Thompson, Grzegorz S. Nowakowski, David J. Inwards, Cristine Allmer, Emmanuelle Nicolas-Virelizier, Catherine Sebban, Pierre Biron, Catherine Chassagne-Clement, Therese Gargi, William R Macon, Andrew L. Feldman, Sergei I Syrbu, Susan L Slager, Thomas E. Witzig, Thomas M Habermann, Brian K Link, James R Cerhan
Institutions: Mayo Clinic, Centre Léon Bérard, University of Iowa
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2529703168